Publication | Open Access
Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer
117
Citations
25
References
2022
Year
ClinicalTrials.gov Identifier: NCT02873195.
| Year | Citations | |
|---|---|---|
Page 1
Page 1